Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Oral Oncol. 2020 Apr 2;105:104635. doi: 10.1016/j.oraloncology.2020.104635

Table 3.

Summary of statistical trends of FLIM-derived features in Moderate and High-Grade Dysplasia/SCC vs. Normal. TRFS:Time-Resolved Fluorescence Spectroscopy; FLIM:Fluorescence Lifetime Imaging; MPM-FLIM:Multiphoton FLIM; AFS:Autofluorescence Spectroscopy; CFM:Confocal Fluorescence Microscopy; SLS:Synchronous Luminescence Spectroscopy

Emission Channel Associated Fluorophore FLIM-Derived Autofluorescence Features Moderate and High-Grade Dysplasia / SCC vs. Normal
Observed Trend Previous Studies [Ref.]
In Vivo AFS: Hamsters [33]
I390 Ex Vivo CFM: Patients [20]
I390,n Ex Vivo SLS: Patients [31]
In Vivo FLIM: Hamsters [32]
390 ± 20 nm Collagen In Vivo TRFS: Patients [25]
τa,v,g,390 Not Reported
αfast,390 No Change Not Reported
τfast,390 Not Reported
τslow,390 Not Reported
In Vivo FLIM: Patients [2]
I452 In Vivo AFS: Hamsters [33]
I452,n Ex Vivo SLS: Patients [31]
452 ± 22.5 nm NADH τa,v,g,452 In Vivo TRFS: Patients [25]
In Vivo FLIM: Patients [2]
In Vivo FLIM: Hamsters [32]
Ex Vivo FLIM: Patients [24]
In Vivo TRFS: Patients [25]
αfast,452 Not Reported
τfast,452 In Vivo MPM-FLIM: Hamsters [18]
Ex Vivo TRFS: Patients [23]
τslow,452 No Change In Vivo MPM-FLIM: Hamsters [18]
In Vivo AFS: Hamsters [33]
I500 Ex Vivo CFM: Patients [20]
I500,n Ex Vivo SLS: Patients [31]
In Vivo TRFS: Patients [25]
> 500 nm FAD τavg,500 Ex Vivo FLIM: Patients [24]
αfast,500 In Vivo MPM-FLIM: Hamsters [18]
τfast,500 No Change In Vivo MPM-FLIM: Hamsters [18]
τslow,500 Not Reported
452 / 500 nm Redox-Ratio = NADH / FAD I452/I500 In Vivo AFS: Hamsters [33]
Ex Vivo FLIM: Patients [24]